Cyano-, Nitrile-

Xylene cyanol is a chemical compound that belongs to the group of phenols. It has been shown to be active in vitro against human skin cancer cells, and induces cell lysis. Xylene cyanol has also been found to bind to the BCR-ABL kinase domain, which is an enzyme that plays a crucial role in the development of leukemia and other autoimmune diseases. Xylene cyanol binds to dna binding domains on the protein surface and forms an adduct with bcr-abl kinase, which inhibits its activity. This inhibition prevents activation of this enzyme and leads to cell death by preventing DNA synthesis.

4-Amino-2-cyanotoluene is a quinazoline compound that inhibits the synthesis of thymine, which is necessary for DNA replication. This compound binds to the enzyme thymidylate synthetase, thereby inhibiting the synthesis of thymine. The inhibitory effect has been shown in a study using calf thymus DNA. 4-Amino-2-cyanotoluene also inhibits the synthesis of other nucleic acids such as adenine and guanine.

2-Chloro-4-fluorobenzonitrile is a drug that has been shown to have antitumor effects by binding to the CB2 receptor. It inhibits hydrogenation reduction of the molecule, which may be due to its ability to react with both functional groups. 2-Chloro-4-fluorobenzonitrile has also been shown to inhibit progesterone receptor, which may lead to an increase in progesterone levels and a decrease in estrogen levels. The pharmacokinetic properties of this compound are not yet known.

4-Aminophenylacetonitrile is a molecule that is structurally similar to nitrobenzene. 4-Aminophenylacetonitrile has been shown to be an efficient method for inhibiting faecalis growth and secretory phospholipase A2 (sPLA2) activity in vitro. It also inhibits the population growth of E. coli in vivo, which can be attributed to its ability to inhibit the enzyme catalysed by hydrogen bond formation.

4-Cyanobenzylamine HCl is a degradable polymer that has been shown to inhibit colonic adenocarcinoma in mice. This compound was synthesized by the reaction of 4-cyanobenzylamine with 3-mercaptopropionic acid and was characterized using IR, 1H NMR, and 13C NMR spectroscopy. It also showed an inhibitory effect on the proliferation of human colon cancer cells. The polymer was found to gel when mixed with different concentrations of acrylamide and methylene bisacrylamide. Gelation occurred at a lower concentration of acrylamide than the amount used in previous studies. This may be due to its functional groups and morphology, which could have contributed to the inhibition of cell growth.

2-Bromo-5-chlorophenylacetonitrile is an organic compound that is used as a reagent and building block in the synthesis of other chemicals. It is a colourless liquid that can be used to synthesize complex compounds. 2-Bromo-5-chlorophenylacetonitrile has been shown to be useful in the synthesis of pharmaceuticals, pesticides, and herbicides. This chemical can be used as a versatile intermediate or building block for the production of high quality research chemicals and specialty chemicals. 2-Bromo-5-chlorophenylacetonitrile is not on the list of chemical substances classified as hazardous according to EU regulation (EINECS) No. 231-1003.

4-Cyanobenzamide is a naphthalene derivative that is both reactive and intramolecular. It has been shown to react with the amino group of peptides, forming a ruthenium complex. The functional groups are acceptors and donors that can be used in assays for the detection of anions or cations. 4-Cyanobenzamide reacts with water to release hydrogen gas, which can be used to measure its hydration ability. This compound has been synthesized using solid-phase synthesis and it has amide bonds that vibrate at a specific frequency.

2-Cyanocinnamic acid is a fatty acid that has been shown to inhibit the synthesis of proteins. It binds to cytochrome c oxidase, inhibiting mitochondrial respiration and electron transport, leading to decreased ATP production. 2-Cyanocinnamic acid is not easily transported out of mitochondria, which leads to its accumulation in the mitochondrial matrix. This accumulation causes synergistic inhibition with glutamate, leading to a decrease in ATP production and an increase in intracellular levels of reactive oxygen species (ROS). The use of 2-cyanoacrylic acid as a mitochondrial transport inhibitor has been proposed for the treatment of obesity and diabetes.
2-Cyanocinnamic acid also inhibits fatty acid uptake by binding to the protein translocase at the outer membrane of cells. This binding prevents monomers from entering the cell, where they are broken down by beta oxidation and converted into acetyl-CoA, which can be used for energy production or stored as triglycer

4-Hydroxyphenylacetonitrile (HPA) is a chemical compound that belongs to the group of nitriles. It is a precursor to the pigment sinalbin, which is found in corynebacterium and related bacteria. HPA has been shown to have an apoptotic effect on human cells, which may be due to its ability to inhibit protein synthesis and induce DNA fragmentation. The synthetic pathway for HPA starts with the conversion of L-phenylalanine into 4-hydroxyphenylpyruvic acid by a wild-type strain or bacterial strain. The 4-hydroxyphenylpyruvic acid is then converted into 4-hydroxybenzaldehyde through polymerase chain reactions or expression plasmids in corynebacterium glutamicum. This molecule can then be transformed into HPA by hydrolysis with hydrochloric acid or enzymatic activity. HPA has also been shown to stimulate

3-Bromobenzylamine is a chemical compound that belongs to the class of amines. It is used as an intermediate in organic synthesis, and its derivative 3-bromobenzylamine hydrochloride is used in pharmaceuticals as a heart stimulant. 3-Bromobenzylamine can be synthesized by reacting an amine with phosgene and then brominating it. This chemical has been shown to have inhibitory activity against cancer cells and can be used for the treatment of cancer. 3-Bromobenzylamine has also been shown to inhibit the growth of bacteria, fungi, and viruses in vitro. 3-Bromobenzylamine may also be useful for treating psoriasis due to its ability to inhibit prostaglandin synthesis.

2-Nitrobenzylamine hydrochloride is a compound that has been shown to have cancer-fighting properties. It inhibits the synthesis of proteins necessary for the proliferation of cancer cells, but it does not affect the synthesis of proteins in healthy cells. This drug is used to diagnose and treat certain types of cancers, such as lymphoma and leukemia. 2-Nitrobenzylamine hydrochloride can be modified by genetic engineering techniques to specifically target cancer cells, which may help with the treatment of other types of diseases in the future. It is believed that this drug will be useful for treating cancers that are resistant to chemotherapy or radiation therapy, as well as those that are caused by mutations in DNA.

Please enquire for more information about N-(2-Cyanophenyl)-2-chloropropanamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about Methyl-2-isocyanoisobutyrate including the price, delivery time and more detailed product information at the technical inquiry form on this page

2,4,6-Trimethylbenzonitrile (TMBN) is a reactive unsaturated ketone that reacts with phosphorus pentachloride to form the corresponding chloroform. It is used in nucleophilic substitution reactions and can be hydrolyzed by hydrochloric acid to form an n-oxide. The reaction mechanism of TMBN with phosphorus pentachloride has been studied using molecular modeling and NMR spectroscopy. TMBN can be converted into an oxide, which can react with hydrogen chloride to form the corresponding chloroform. Reaction products include the 2,4,6-trichlorobenzonitrile (TCBN), which is a carcinogen.

3-Cyanoethylbenzoic acid is an anthropogenic compound that is produced by the Friedel-Crafts reaction between benzoyl chloride and acrylonitrile in the presence of a base. 3-Cyanoethylbenzoic acid is used as a solvent for chromatographic methods, such as gradient elution, ion exchange, and reversed phase. 3-Cyanoethylbenzoic acid has been used to determine the optical purity of benzoate salts and amides. This compound can be taken orally in solid oral dosage form or enterically in liquid oral dosage form. 3-Cyanoethylbenzoic acid interacts with other drugs that are metabolized by CYP3A4, such as erythromycin, to produce an active metabolite (N-desmethyldesipramide).

Ethyl 2,3-dicyanopropionate is a white crystalline solid that is soluble in organic solvents. It has the molecular formula CHClNOS and the molecular weight of 138.1 g/mol. This compound has a melting point of 92 °C and can be purchased as a mixture of cis and trans isomers. The cis form melts at 93 °C and the trans form melts at 88 °C. Ethyl 2,3-dicyanopropionate is synthesized from chlorobenzene by dehydrating it with hydrochloric acid in an organic solvent. It can also be prepared by reacting ethyl cyanoacetate with ammonia in an inert atmosphere. Impurities may include chloride, sulfoxide, or imine.